Bristol Myers faces renewed, $6.7 billion lawsuit over delayed cancer drug

By Yahoo! Finance | Nov 14, 2024 at 07:34 PM EST

Bristol Myers Squibb faces a $6.7 billion lawsuit for allegedly delaying drug approvals, cheating former Celgene shareholders. The lawsuit claims the delay cost shareholders an extra $9 per share in cash. UMB Bank, now confirmed as trustee, filed the lawsuit after a previous dismissal.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.